For the Inventor, By the Inventor

Enter assignee name

San Francisco, CA, United States of America

Neumora Therapeutics, Inc.

USPTO Granted Patents = 19

EPO Patents = 5

Trademarks = 3

Forward Citations = 4

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Matthew Edward Kollada (6 out of 8 patents)

Parvez Ahammad (5 out of 16 patents)

Yuelu Liu (5 out of 9 patents)

4. Humberto Andres Gonzalez Cabezas (5 out of 9 patents)

5. William J Martin (5 out of 7 patents)

6. Tathagata Banerjee (5 out of 5 patents)

7. Monika Sharma Mellem (4 out of 7 patents)

8. Pablo Christian Gersberg (3 out of 4 patents)

9. Gary Brandt (3 out of 6 patents)

10. Dilinie Fernando (2 out of 11 patents)

11. Anne-Marie Beausoleil (2 out of 32 patents)

12. Robert M Jones (2 out of 85 patents)

13. Zhihua Ma (2 out of 31 patents)

14. Mariangela Urbano (2 out of 11 patents)

15. David Hardick (2 out of 6 patents)

19 patents: Sort by Forward Citations

1. 12371414 - Methods of treating neurological disorders (2025-07-29),

2. 12247037 - 1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-A][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders (2025-03-11),

3. 12232848 - System and method of facial analysis (2025-02-25),

4. 12171758 - Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto (2024-12-24),

5. 12152038 - Vasopressin receptor antagonists and products and methods related thereto (2024-11-26),

6. 12087446 - Multimodal dynamic attention fusion (2024-09-10),

7. 12002590 - Machine learning-based diagnostic classifier (2024-06-04),

8. 11993580 - Methods of treating neurological disorders (2024-05-28),

9. 11942224 - System and method for identifying transdiagnostic features shared across mental health disorders (2024-03-26),

10. 11887724 - Estimating uncertainty in predictions generated by machine learning models (2024-01-30),

11. 11858943 - Vasopressin receptor antagonists and products and methods related thereto (2024-01-02),

12. 11857322 - Systems and methods for screening, diagnosing, and stratifying patients (2024-01-02),

13. 11842793 - Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject (2023-12-12),

14. 11798681 - Machine learning systems for training encoder and decoder neural networks (2023-10-24),

15. 11791016 - Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping data (2023-10-17),

Neumora Therapeutics, Inc. is a biotechnology company focused on the development of innovative therapies for neurological disorders. Our mission is to improve the lives of patients suffering from conditions such as Alzheimer's disease and Parkinson's disease. We are dedicated to advancing cutting-edge research and translating scientific discoveries into treatments that make a meaningful impact on patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#240 in San Francisco, CA

#3,975 in California

#16,629 in US

#31,713 in the World

San Francisco, CA, United States of America

Neumora Therapeutics, Inc.

Forward Citations = 4

37 inventors:

Matthew Edward Kollada (6 out of 8 patents)

Parvez Ahammad (5 out of 16 patents)

Yuelu Liu (5 out of 9 patents)

4. Humberto Andres Gonzalez Cabezas (5 out of 9 patents)

5. William J Martin (5 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…